(Q50668498)

17 March 2018

title

Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice. (English)

1 reference

17 March 2018

0 references

0 references

0 references

1 reference

1 reference

María S García-Gutiérrez

series ordinal

1

1 reference

17 March 2018

Jorge Manzanares

series ordinal

2

1 reference

17 March 2018

language of work or name

English

0 references

publication date

13 September 2010

1 reference

17 March 2018

Journal of Psychopharmacology

published in

1 reference

17 March 2018

volume

25

1 reference

17 March 2018

page(s)

111-120

1 reference

17 March 2018

issue

1

1 reference

17 March 2018

Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

The role of corticotropin-releasing factor in depression and anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Cerebrospinal fluid neuropeptides in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Assembly and cell surface expression of heteromeric and homomeric gamma-aminobutyric acid type A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

GABA A/Bz receptor subtypes as targets for selective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Cannabinoids modulate ultrasound-induced aversive responses in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Control of the cell survival/death decision by cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

The role of early adverse life events in the etiology of depression and posttraumatic stress disorder. Focus on corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Analysis of GABAA receptor assembly in mammalian cell lines and hippocampal neurons using gamma 2 subunit green fluorescent protein chimeras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

The use of a plus-maze to measure anxiety in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Molecular and neuronal substrate for the selective attenuation of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Cannabinoid receptors as therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Functional CB2 type cannabinoid receptors at CNS synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

23 Punch sampling biopsy technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Type I and type II GABAA-benzodiazepine receptors produced in transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110379507

21 January 2018

Identifiers

DOI

10.1177/0269881110379507

1 reference

17 March 2018

PubMed ID

20837564

1 reference

17 March 2018